DRUGS see also Crime; Pharmaceuticals

Amendments

Alaska: enter into intergovernmental agreements with Indian tribes relative to enforcement of certain State laws by Indian tribes, improve quality of life in rural Alaska, and reduce alcohol and drug abuse (S. 1474), S6416, S6454 [9DE]

Articles and editorials

Children of the Drug Wars—A Refugee Crisis, Not an Immigration Crisis, H7140–H7142 [31JY], E1258 [29JY]

How a Vermont Hospital Fights the American Opioid Epidemic, S3362 [3JN]

‘Out of Options’—Veterans With PTSD Hit Pot Underground, H3344 [30AP]

Pots of Marijuana Cash Cause Security Concerns, H6269 [15JY]

Treatment or Jail—Patrick Kennedy Wages Fierce Anti-Pot Crusade, S1275 [4MR]

Bills and resolutions

Chemicals: allow marketing, distribution, or sale of solid antimicrobial copper alloys with certain claims and exclude certain solid antimicrobial copper alloys from regulation as drugs or devices (see H.R. 5350), H7182 [31JY]

Children and youth: enhance the safety of drug-free playgrounds (see S. 2241), S2378 [10AP]

——— provide for identification and dissemination of best practices for medical professionals and other health care providers relative to neonatal abstinence syndrome (see H.R. 4888), H5494 [18JN]

——— provide for identification and dissemination of evidence-informed recommendations for addressing maternal addiction and neonatal abstinence syndrome and study neonatal abstinence syndrome (see S. 2722), S5216 [31JY]

Clinical Research Innovation Month: designate (see H. Res. 733), H7675 [17SE]

Cocaine: reclassify certain low-level felonies as misdemeanors and eliminate increased penalties for cocaine offenses where the cocaine involved is cocaine base (see S. 2657), S4903 [24JY]

Commission on Native Children: establish (see H.R. 4908), H5557 [19JN]

Contraceptives: ensure employers cannot prohibit access, call for an FDA study on whether prescriptions are necessary for contraceptives, and allow use of certain health accounts to purchase over-the-counter drugs (see S. 2605), S4502 [15JY]

——— establish certain duties for pharmacies to ensure provision of FDA-approved contraception (see S. 2625), S4620 [17JY]

Courts: provide certain protections from civil liability for individuals prescribing or administering opioid overdose drugs (see S. 2092), S1365 [6MR] (see H.R. 4288), H2610 [24MR]

DEA: improve regulation of anabolic steroids (see S. 2012), S890 [11FE] (see H.R. 4771), H5022 [29MY]

Death and dying: reduce deaths occurring from overdoses (see S. 2755), S5217 [31JY] (see H.R. 4169), H2255 [6MR]

Dept. of Agriculture: prohibit use of Supplemental Nutrition Assistance Program benefits to purchase marijuana products (see H.R. 4142), H2147 [4MR]

Dept. of HHS: amend and reauthorize the Controlled Substance Monitoring Program (see S. 2529), S4003 [25JN]

——— prevent abuse of dextromethorphan by restricting over-the-counter sales and bulk distribution (see H.R. 3969), H1510 [29JA]

——— require NIH to consider sex differences in medical research and direct FDA to guarantee clinical drug trials are sufficient to determine safety and effectiveness for both men and women (see H.R. 4879), H5398 [17JN]

Dept. of Homeland Security: make anthrax vaccines and antimicrobials available to emergency response providers (see H.R. 5620), H7885 [18SE]

Dept. of Justice: award grants to address prescription opioid abuse and heroin use (see S. 2839), S5697 [17SE] (see H.R. 5845), H9044 [10DE]

——— establish National Parents Corps Program (see H.R. 5623), H7885 [18SE]

——— exempt certain products from Controlled Substances Act requirements on scheduled listed chemicals if it is not practical to use such products in illicit manufacture of methamphetamine (see H.R. 4502), H3240 [28AP]

——— improve enforcement efforts relative to prescription drug diversion and abuse (see H.R. 4069), H1780 [18FE] (see H.R. 4709), H4784 [21MY]

Dept. of Labor: issue implementing regulations for drug testing under State unemployment compensation programs (see H.R. 4310), H2695 [26MR]

Dept. of Veterans Affairs: authorize health care providers to provide recommendations and opinions to veterans regarding participation in State marijuana programs (see H.R. 5762), H8169 [20NO]

Diseases: commend progress made by, and reaffirm commitment to, anti-tuberculosis programs (see S. Res. 393), S1691 [24MR]

——— facilitate effective research on, and treatment of, neglected tropical diseases through coordinated domestic and international efforts (see H.R. 4847), H5318 [11JN]

Drug abuse: address prescription opioid and heroin abuse (see S. 2504), S3863 [19JN]

——— reduce opioid misuse and abuse (see H.R. 5587), H7884 [18SE]

FDA: create a limited population pathway for approval of certain antibacterial drugs (see S. 2996), S6540 [10DE]

——— ensure eligible product developers have competitive access to approved drugs and licensed biological products to enable development and testing of new products (see H.R. 5657), H7886 [18SE]

——— ensure that liquid over-the-counter medications are packaged with appropriate dosage delivery devices and, in the case of such medications labeled for pediatric use, appropriate flow restrictors (see H.R. 5613), H7885 [18SE]

——— establish recall authority for drugs and increase criminal penalties for sale or trade of knowingly adulterated or misbranded prescription drugs (see H.R. 5874), H9303 [11DE]

——— expand priority review voucher incentive program to encourage treatments for tropical diseases (see H.R. 5729), H8071 [18NO]

——— expedite review of pharmaceuticals approved for marketing in the European Union (see H.R. 4918), H5557 [19JN]

——— extend market exclusivity periods for drugs approved to prevent, diagnose, or treat a rare disease or condition (see H.R. 5750), H8169 [20NO]

——— incentivize the development of treatments and vaccines for ebola by adding the disease to priority review voucher program (see S. 2917), S5918 [12NO]

——— reform program allowing for expanded access to certain experimental treatments or breakthrough drugs for seriously ill patients (see H.R. 5805), H8867 [8DE]

——— withdraw approval for the drug Zohydro ER and prohibit from approving such drug unless it is reformulated to prevent abuse (see S. 2134), S1652 [13MR] (see H.R. 4241), H2433 [13MR]

FTC: issue rules to promote competition and help consumers save money by giving them the freedom to choose where they buy prescription pet medications (see S. 2756), S5217 [31JY] (see H.R. 4023), H1718 [10FE]

Government regulations: exclude therapeutic hemp and cannabidiol from the definition of marijuana (see H.R. 5226), H6976 [28JY]

——— improve DEA scheduling process for new FDA-approved drugs under the Controlled Substances Act and registration process for use of controlled substances in clinical trials (see S. 2862), S5782 [18SE] (see H.R. 4299), H2694 [26MR]

Health: enhance efforts to address antimicrobial resistance (see S. 2236), S2378 [10AP]

——— support regenerative medicine through research funding and commercial development and develop a regulatory environment that enables rapid approval of safe and effective products (see H.R. 4494), H3240 [28AP]

——— support role of the U.S. in ensuring children in poor countries have access to vaccines and immunization through the GAVI Alliance (organization) (see S. Res. 578), S5993 [13NO] (see H. Res. 688), H6859 [25JY]

Health care professionals: increase access to opioid addiction treatment by expanding ability of medical professionals to provide medication-assisted therapies (see S. 2645), S4762 [23JY]

——— increase number of opioid abusing or addicted patients that providers may treat in an outpatient setting and allow qualified nurse practitioners and physician assistants to treat such patients (see S. 2825), S5628 [16SE]

Immigration: secure the border between the U.S. and Mexico (see H.R. 5316), H7181 [31JY]

International Self-Care Day: designate (see S. Res. 515), S4763 [23JY]

Law enforcement: improve prosecution of the sale and distribution of synthetic drugs known as analogues (see H.R. 4975), H5768 [25JN]

——— provide for State enforcement of border security (see H.R. 5400), H7241 [1AU]

Marijuana: provide for legitimate use of medicinal marijuana in accordance with State laws (see H.R. 4498), H3240 [28AP]

Medicaid: apply requirement that drug manufacturers that increase prices faster than inflation pay an additional rebate to State Medicaid programs to generic drug manufacturers (see S. 2948), S6204 [20NO] (see H.R. 5748), H8169 [20NO]

——— establish a demonstration project under which payment may be made to States for expenditures for medical assistance for substance use disorder treatment services (see H.R. 5136), H6397 [17JY]

Medicare: ensure equal access of beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage (see H.R. 4577), H3446 [6MY]

——— establish Value-Based Insurance Design demonstration program to show that reduced copayments or coinsurance can increase utilization, improve clinical outcomes, and lower health care expenditures (see S. 2783), S5507 [10SE] (see H.R. 5183), H6745 [23JY]

——— modify payment for outpatient department procedures that utilize drugs as supplies (see S. 2980), S6350 [4DE] (see H.R. 4857), H5363 [12JN]

——— prohibit further action on the proposed rule on changes to prescription drug benefit programs (see H.R. 4160), H2255 [6MR]

——— provide coverage of pharmacist services in medically underserved areas (see H.R. 4190), H2300 [11MR]

——— provide for coverage of home as a site of care for infusion therapy (see H.R. 5435), H7433 [10SE]

——— provide for pharmacy benefits manager standards under the prescription drug program and transparency of payment methodology of pharmacies (see H.R. 4437), H3143 [9AP] (see H.R. 5815), H8931 [9DE]

——— treatment of patient encounters in ambulatory surgical centers in determining meaningful electronic health records use (see H.R. 5556), H7883 [18SE]

Medicare/Medicaid: provide for equitable treatment of residents of territories relative to low-income subsidies under the Medicare prescription drug benefit program (see H.R. 3966), H1510 [29JA]

National Drug Take-Back Week: designate (see S. Res. 466), S3367 [3JN]

National Guard: achieve operational control of the international border between the U.S. and Mexico through deployment of members in support of the Bureau of Customs and Border Protection (see H.R. 4882), H5398 [17JN]

National Prescription Opioid and Heroin Abuse Awareness Month: designate (see S. Res. 466), S3367 [3JN]

National security: improve border security (see H.R. 4962), H5767 [25JN]

National Youth Synthetic Drug Awareness Week: designate (see S. Res. 389), S1653 [13MR]

Office of National Drug Control Policy: strike provisions that prohibit from studying the legalization of marijuana and that require opposition to any attempt to legalize marijuana (see H.R. 4046), H1770 [11FE]

Patents: advance public health by encouraging independent innovators to pursue drug repurposing research and develop new treatments and cures by providing intellectual property protections for those innovations (see S. 2150), S1691 [24MR] (see H.R. 4287), H2610 [24MR]

Pharmaceuticals: allow importation, distribution, and sale of investigational drugs and devices intended for use by terminally ill patients (see H.R. 5854), H9302 [11DE]

——— allow manufacture, importation, distribution, and sale of investigational drugs and devices intended for use by terminally ill patients (see H.R. 4475), H3196 [10AP]

——— allow personal importation of safe and affordable drugs from approved pharmacies in Canada (see S. 2549), S4153 [26JN]

——— establish a new class of ‘‘dormant therapy’’ drugs to remove disincentives to the development of certain treatments relative to the length of patent protections (see S. 3004), S6626 [11DE]

Public welfare programs: prohibit assistance under Temporary Assistance for Needy Families Program from being accessed through an electronic benefit transfer card at stores that sell marijuana (see H.R. 4137, 4142), H2147 [4MR]

Research: encourage development and use of new antimicrobial drugs in order to treat antibiotic-resistant infections (see H.R. 4187), H2300 [11MR]

Roads and highways: establish requirements relative to marijuana impaired driving (see H.R. 4179), H2256 [6MR]

Substance Abuse and Mental Health Services Administration: award grants to States to expand access to clinically appropriate services for opioid abuse, dependence or addiction (see H.R. 5339), H7182 [31JY]

U.S. Anti-Doping Agency: reauthorize (see S. 2338), S3029 [14MY] (see H.R. 5614), H7885 [18SE]

U.S. Sentencing Commission: disapprove amendment to sentencing guidelines for certain drug offenses (see H.R. 5605), H7884 [18SE]

Western Hemisphere Drug Policy Commission: establish (see H.R. 4640), H4058 [9MY]

Letters

Ensuring Patient Access and Effective Drug Enforcement Act: Representative Goodlatte, Committee on the Judiciary (House), H7005 [29JY]

——— Representative Upton, Committee on Energy and Commerce (House), H7005 [29JY]

Medicaid expansion funding in Florida: Kathleen Voss Woolrich, E463 [27MR]

Medical Preparedness Allowable Use Act: Hank Clemmensen, International Association of Fire Chiefs, H1518 [3FE]

——— Jeff Walker, International Association of Emergency Managers, H1519 [3FE]

——— Tim Stephens, Emergency Services Coalition for Medical Preparedness, H1518 [3FE]

Veterinary Medicine Mobility Act: Representative Goodlatte, Committee on the Judiciary (House), H5835 [8JY]

——— Representative Upton, Committee on Energy and Commerce (House), H5835 [8JY]

Lists

DEA agents killed in the line of duty, H4939 [29MY]

Messages

National Drug Control Strategy: President Obama, S4330 [9JY], H6032 [9JY]

Remarks in House

Center for Medicine in the Public Interest: tribute to My Life Is Worth It Campaign, E1421 [16SE]

Children and youth: provide for identification and dissemination of best practices for medical professionals and other health care providers relative to neonatal abstinence syndrome (H.R. 4888), H5882 [9JY]

Clinical Research Innovation Month: designate (H. Res. 733), H7863 [18SE]

Committee on Homeland Security and Governmental Affairs (Senate): hearing on statehood for the District of Columbia, H7447–H7450 [11SE]

Committee on Oversight and Government Reform (House): hearing on decriminalization of marijuana in the District of Columbia, H3368, H3396–H3398 [1MY], H5357 [12JN]

Crime: effect of immigration on domestic drug control, H8265 [2DE]

——— impact of war on drugs on violent crime, H6042 [10JY]

DEA: administrative spending, salaries, and expense accounts funding, H4936–H4939 [29MY]

——— improve regulation of anabolic steroids (H.R. 4771), H7459–H7461 [15SE]

Dept. of Agriculture: Distance Learning, Telemedicine, and Broadband Program funding through reductions in Grain Inspection, Packers and Stockyards Administration funding, H5296 [11JN]

Dept. of Defense: include additional community partnerships through a competitive and merit-based process to enhance mental health programs for National Guard and Reserve components, H5442 [18JN]

Dept. of Homeland Security: develop a comprehensive strategy to gain and maintain operational control of the international borders of the U.S. (H.R. 1417), H129 [9JA], H6223 [15JY]

Dept. of Justice: authorize veterans’ treatment courts and encourage services for veterans through drug courts (H.R. 2187), H3064 [9AP]

——— call for investigation of operations transferring firearms to drug cartels where U.S. law enforcement personnel do not monitor such firearms, H10 [7JA]

——— condition reduction of Deputy Attorney General Office salaries account funding on enforcement of Federal laws relative to marijuana use, H4906–H4908 [28MY]

——— drug court program funding, H4880, H4881 [28MY]

——— establish National Parents Corps Program (H.R. 5623), E1473 [19SE]

——— improve enforcement efforts relative to prescription drug diversion and abuse (H.R. 4709), H7004–H7007 [29JY]

——— investigation relative to operations transferring firearms to drug cartels in Mexico, H3190 [10AP]

——— mental health courts and veterans treatment courts funding, H4890, H4891 [28MY]

——— Organized Crime Drug Enforcement Task Force funding through reductions in Bureau of the Census funding, H4888 [28MY]

——— Prescription Drug Monitoring Program funding, H4928 [29MY]

——— prohibit funding to prevent States from implementing laws that authorize the use, distribution, possession, or cultivation of medical marijuana, H4878 [28MY], H4982–H4985 [29MY], H5358 [12JN], E1034 [20JN]

——— proposal to offer clemency to non-violent drug offenders, H1528 [3FE]

——— veterans treatment courts funding, H4901, H4902 [28MY], H4944 [29MY]

——— veterans treatment courts funding through reductions in ATF salaries and expenses account funding, H4941, H4942 [29MY]

Dept. of the Treasury: prohibit funding to implement compliance guidelines for financial institutions seeking to provide services to marijuana-related businesses, H6268–H6270 [15JY]

——— prohibit funding to penalize financial institutions for providing services to marijuana-related businesses in States with legalized marijuana, H6272, H6275, H6276 [15JY]

Dept. of Veterans Affairs: authorize health care providers to provide recommendations and opinions to veterans regarding participation in State marijuana programs (H.R. 5762), E1657 [20NO]

——— prohibit funding to implement directive prohibiting access to clinical programs for veterans participating in State-approved marijuana programs, H3344–H3349 [30AP], H8035 [18NO]

Diseases: commend progress made by, and reaffirm commitment to, anti-tuberculosis programs, E425 [24MR]

——— efforts to contain Ebola outbreak in Africa, E1346 [8SE]

——— facilitate effective research on, and treatment of, neglected tropical diseases through coordinated domestic and international efforts (H.R. 4847), E1346 [8SE]

——— require group and individual health insurance coverage and group health plans to cover oral cancer drugs on terms no less favorable than for cancer medications administered by a health care provider (H.R. 1801), H2699 [27MR]

District of Columbia: discourage congressional intervention in marijuana legalization initiative, H7972 [13NO], H7989–H7993 [14NO]

——— prohibit funding for needle exchange programs, H6125 [11JY]

——— prohibit funding to decriminalize marijuana, H6046, H6047 [10JY], H6125–H6127 [11JY], H6179, H6180 [14JY], H6853–H6857 [25JY], H9073, H9277, H9285 [11DE]

Edgewater Systems for Balanced Living, Inc.: anniversary, E1511 [12NO]

FDA: expedite approval of certain pharmaceuticals and experimental treatments used in cancer treatments, E1424 [16SE]

——— extend market exclusivity periods for drugs approved to prevent, diagnose, or treat a rare disease or condition (H.R. 5750), H8938 [10DE]

——— funding, H5260 [11JN]

——— improve priority review voucher incentive program for expedited review of treatments for tropical and rare pediatric diseases, E1321 [1AU]

——— incentivize the development of treatments and vaccines for ebola by adding the disease to priority review voucher program (S. 2917), H8344 [3DE]

FEMA: codify authority to use Urban Areas Security Initiative and State Homeland Security Grant Program funding for enhancing medical preparedness, medical surge capacity, and mass prophylaxis capabilities (H.R. 1791), H1518–H1520 [3FE], E160 [4FE]

Financial institutions: create protections for depository institutions that provide financial services to marijuana-related businesses (H.R. 2652), H2659 [26MR], H7944 [13NO]

Gainesville, GA: anniversary of Riverside Pharmacy, H8 [7JA]

Gateway Foundation: Alcohol and Drug Treatment Centers renewed Joint Commission accreditation, E200 [11FE]

Hardy, Josh: tribute to support of family and friends relative to appeal to FDA for expedited approval of experimental drug treatment, H2369 [13MR]

Health: promote development of meaningful treatments for patients (H.R. 3091), H2004 [27FE]

——— promote development of meaningful treatments for patients (H.R. 3116), H4480 [20MY]

Heroin: funding to combat epidemic, H1649 [5FE]

Holder, Attorney General: express no confidence due to lack of monitoring and actions relative to operations transferring firearms to drug cartels in Mexico, H3442 [6MY]

——— impeach (H. Res. 411), H6663 [23JY]

Immigration: secure the border between the U.S. and Mexico, H8150 [20NO]

Laos: U.S. policy, E1576 [14NO]

Law enforcement: focus limited Federal resources on the most serious offenders by modifying sentencing guidelines for certain drug offenses, E339 [10MR]

LSC: funding through reductions in DEA funding, H4930, H4931 [29MY]

Marijuana: change Federal classification relative to impact and danger, H1661 [6FE], H1721 [11FE]

——— decriminalize marijuana at the Federal level and leave States the power to regulate and tax marijuana, H7300 [9SE]

——— decriminalize marijuana at the Federal level and leave States the power to regulate marijuana similar to the power to regulate alcohol, H6662 [23JY], H6863, H6865 [28JY]

——— decriminalize marijuana at the Federal level and leave States the power to regulate marijuana similar to the power to regulate alcohol (H.R. 499), H185 [14JA]

——— prohibit Federal prosecution of residents who are acting in accordance with their State’s marijuana laws (H.R. 1523), H2659 [26MR], H7992 [14NO]

——— provide an affirmative defense for medical use in accordance with the laws of the States (H.R. 710), H2659 [26MR]

——— reschedule under the Controlled Substances Act and allow for medicinal use in accordance with State laws, H2995 [8AP], H4053–H4055 [9MY]

Medicare: importance of Part D generic drug pricing, H3138–H3141 [9AP]

——— provide for coverage of home as a site of care for infusion therapy (H.R. 5435), E1378 [10SE]

——— provide for pharmacy benefits manager standards under the prescription drug program and transparency of payment methodology of pharmacies (H.R. 4437), H3138–H3141 [9AP]

National Association of Chain Drug Stores: observance of RxIMPACT Day, E304 [5MR]

——— drug interdiction and counter-drug activities funding through reductions in Dept. of Defense operation and maintenance funding, H5453 [18JN]

National security: improve border security, H7118 [30JY]

NIH: funding, E1629 [19NO]

Obama, President: condemn remarks relative to dangers of marijuana use, H1528 [3FE]

Rockford, IL: anniversary of Rockford Rescue Mission, E356 [11MR]

Taxation: allow deductions and credits relative to expenditures in connection with marijuana sales conducted in compliance with State law (H.R. 2240), H7944 [13NO]

——— provide for the taxation of marijuana (H.R. 501), H7992 [14NO]

U.S. Anti-Doping Agency: reauthorize (S. 2338), H10314 [12DE]

U.S. Sentencing Commission: decision to retroactively modify sentencing guidelines for certain drug offenses, E1203 [22JY]

Veterinarians: allow transport and dispensing of controlled substances in the usual course of veterinary practice outside of the registered location (H.R. 1528), H5834–H5836 [8JY]

Western Hemisphere Drug Policy Commission: establish (H.R. 4640), E730 [9MY]

Remarks in Senate

Committee on the Judiciary (Senate): field hearing held in Rutland, VT, on community solutions to breaking heroin and opioid addiction, S1771 [26MR], S3361 [3JN]

——— establish certain duties for pharmacies to ensure provision of FDA-approved contraception (S. 2625), S4622 [17JY]

Controlled Substances Act: place synthetic drugs in Schedule I indicating high potential for abuse, no current accepted medical use, and lack of accepted safety for use under medical supervision, S1580 [12MR]

Crime: address sentencing disparity between crack and powder cocaine, S4143 [26JN]

——— decriminalization of marijuana, S1274 [4MR]

DEA: improve regulation of anabolic steroids (H.R. 4771), S6696 [11DE]

——— improve regulation of anabolic steroids (S. 2012), S891 [11FE]

——— investigation into detention of Daniel Chong, S5070–S5072 [29JY]

——— issuance of final rule implementing the Secure and Responsible Drug Disposal Act, S1905 [1AP]

Death and dying: reduce deaths occurring from overdoses (S. 2755), S5233 [31JY]

Dept. of Defense: implement price controls for prescription drug program, S2310 [9AP]

Dept. of Homeland Security: develop a comprehensive strategy to gain and maintain operational control of the international borders of the U.S., S4307 [9JY]

——— funding to assist Honduras, Guatemala, and El Salvador in addressing drug trafficking and organized crime, S5107 [30JY]

Dept. of Justice: award grants to address prescription opioid abuse and heroin use (S. 2839), S5701 [17SE]

——— investigation relative to operations transferring firearms to drug cartels in Mexico, S3487 [9JN]

——— proposal to offer clemency to non-violent drug offenders, S2549 [30AP]

——— provide with additional tools to target extraterritorial drug trafficking activity (S. 706), S6840 [15DE]

FDA: funding, S3784 [18JN]

——— incentivize the development of treatments and vaccines for ebola by adding the disease to priority review voucher program (S. 2917), S6271 [2DE]

Hardy, Josh: tribute to support of family and friends relative to appeal to FDA for expedited approval of experimental drug treatment, S1646 [13MR]

Harkin, Senator: impact of Senate achievements on Jasper County, IA, S3288 [22MY]

International Self-Care Day: designate (S. Res. 515), S4846 [23JY]

Law enforcement: focus limited Federal resources on the most serious offenders by modifying sentencing guidelines for certain drug offenses (S. 1410), S2224–S2226 [8AP], S2942 [13MY], S3912 [24JN], S4449 [14JY], S5845 [18SE], S6490 [10DE]

Medicare: release of Committee on Aging (Senate, Special) report, ‘‘Medicare Part D Prescription Drug Benefit—Increasing Use and Access of Affordable Prescription Drugs’’, S6864 [15DE]

National Association of Chain Drug Stores: observance of RxIMPACT Day, S1485 [10MR]

National Drug Take-Back Week: designate (S. Res. 466), S5518 [10SE]

National Prescription Opioid and Heroin Abuse Awareness Month: designate (S. Res. 466), S5518 [10SE]

National security: acknowledge increasing threat of narcoterrorism to national security and ensure law enforcement agencies have proper tools to combat such crimes, S4449 [14JY]

——— provide funding to Navy and Coast Guard to interdict shipments of drugs between South and Central America, S4976 [28JY], S5104, S5105 [30JY]

National Youth Synthetic Drug Awareness Week: designate (S. Res. 389), S1669 [13MR]

——— observance, S1579 [12MR]

Shumlin, Peter: tribute to State of State speech by Governor of Vermont on crisis of heroin addiction, S707 [4FE]

Taxation: proposed merger of Pfizer Inc., and AstraZeneca PLC relative to treatment of existing inversions by corporations to avoid the U.S. corporate tax by reincorporating in a foreign country, S2932–S2935 [13MY]

U.S. Anti-Doping Agency: reauthorize (S. 2338), S6697 [11DE]

Veterinarians: allow transport and dispensing of controlled substances in the usual course of veterinary practice outside of the registered location (H.R. 1528), S4567, S4568 [16JY]

——— allow transport and dispensing of controlled substances in the usual course of veterinary practice outside of the registered location (S. 1171), S185 [8JA]

World Immunization Week: observance, S2552 [30AP]

World Polio Day: support goals and ideals (S. Res. 270), S833 [6FE], S2553 [30AP]

Young Marines (organization): tribute, S6920 [16DE]

Reports filed

Adding Ebola to the FDA Priority Review Voucher Program Act: Committee on Health, Education, Labor, and Pensions (Senate) (S. 2917), S6148 [19NO]

Alaska Safe Families and Villages Act: Committee on Indian Affairs (Senate) (S. 1474), S5373 [8SE]

——— Committee on Indian Affairs (Senate) (S. 1474) (S. Rept. 113–260), S5779 [18SE]

Commission on Native Children Act: Committee on Indian Affairs (Senate) (S. 1622), S5373 [8SE]

——— Committee on Indian Affairs (Senate) (S. 1622) (S. Rept. 113–264), S5918 [12NO]

Designer Anabolic Steroid Control Act: Committee on Energy and Commerce (House) (H.R. 4771) (H. Rept. 113–587), H7527 [15SE]

——— Committee on the Judiciary (House) (H.R. 4771) (H. Rept. 113–587), H7527 [15SE]

Ensuring Patient Access and Effective Drug Enforcement Act: Committee on Energy and Commerce (House) (H.R. 4709) (H. Rept. 113–605), H7881 [18SE]

Improving Regulatory Transparency for New Medical Therapies Act: Committee on Energy and Commerce (House) (H.R. 4299) (H. Rept. 113–565), H7038 [29JY]

——— Committee on the Judiciary (House) (H.R. 4299) (H. Rept. 113–565), H7900 [19SE]

Medicare Part D Prescription Drug Benefit—Increasing Use and Access of Affordable Prescription Drugs: Committee on Aging (Senate, Special) (S. Rept. 113–306), S6626 [11DE]

Smarter Sentencing Act: Committee on the Judiciary (Senate) (S. 1410), S1517 [11MR]

Support Goals and Ideals of World Polio Day: Committee on Foreign Relations (Senate) (S. Res. 270), S761 [4FE]

Support Role of the U.S. in Ensuring Children in Poor Countries Have Access to Vaccines and Immunization Through the GAVI Alliance (organization): Committee on Foreign Relations (Senate) (S. Res. 578), S6349 [4DE]

U.S. Anti-Doping Agency Reauthorization: Committee on Commerce, Science, and Transportation (Senate) (S. 2338) (S. Rept. 113–281), S6234 [1DE]

Veterinary Medicine Mobility Act: Committee on Energy and Commerce (House) (H.R. 1528) (H. Rept. 113–457), H4683 [20MY]

Texts of

H.R. 1528, Veterinary Medicine Mobility Act, H5834 [8JY]

H.R. 1791, Medical Preparedness Allowable Use Act, H1518 [3FE]

H.R. 4137, Preserving Welfare for Needs Not Weed Act, H7603 [16SE]

H.R. 4709, Ensuring Patient Access and Effective Drug Enforcement Act, H7004 [29JY]

H.R. 4771, Designer Anabolic Steroid Control Act, H7459 [15SE]

S. 706, Transnational Drug Trafficking Act, S6840 [15DE]

S. 1171, allow veterinarians to transport and dispense controlled substances in the usual course of veterinary practice outside of the registered location, S185 [8JA]

S. 1474, Alaska Safe Families and Villages Act, S6414–S6416 [9DE]

S. 2338, U.S. Anti-Doping Agency reauthorization, S6697 [11DE], H10314 [12DE]

S. 2722, Protecting Our Infants Act, S5221 [31JY]

S. 2917, Adding Ebola to the FDA Priority Review Voucher Program Act, S6271 [2DE], H8344 [3DE]

S. Res. 270, support goals and ideals of World Polio Day, S833 [6FE]

S. Res. 389, National Youth Synthetic Drug Awareness Week, S1664 [13MR]

S. Res. 393, support goals of World Tuberculosis Day and commend progress made by, and reaffirm commitment to, anti-tuberculosis programs, S1694 [24MR]

S. Res. 466, National Drug Take-Back Week and National Prescription Opioid and Heroin Abuse Awareness Month, S3382 [3JN]

S. Res. 515, International Self-Care Day, S4771 [23JY]

S. Res. 578, support role of the U.S. in ensuring children in poor countries have access to vaccines and immunization through the GAVI Alliance (organization), S5995 [13NO]